These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


552 related items for PubMed ID: 18783726

  • 21. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH, Chiou HY, Hsueh YM, Chen CJ, Yu HJ, Pu YS.
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [Abstract] [Full Text] [Related]

  • 22. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
    Liao CM, Shen HH, Lin TL, Chen SC, Chen CL, Hsu LI, Chen CJ.
    Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
    [Abstract] [Full Text] [Related]

  • 23. Carcinogen exposure and epigenetic silencing in bladder cancer.
    Marsit CJ, Karagas MR, Schned A, Kelsey KT.
    Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
    [Abstract] [Full Text] [Related]

  • 24. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study.
    Hamadani JD, Tofail F, Nermell B, Gardner R, Shiraji S, Bottai M, Arifeen SE, Huda SN, Vahter M.
    Int J Epidemiol; 2011 Dec; 40(6):1593-604. PubMed ID: 22158669
    [Abstract] [Full Text] [Related]

  • 25. Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan.
    Su CC, Lu JL, Tsai KY, Lian IeB.
    Cancer Causes Control; 2011 Jan; 22(1):101-8. PubMed ID: 21052815
    [Abstract] [Full Text] [Related]

  • 26. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008.
    Bachand A, Mundt KA, Mundt DJ, Carlton LE.
    Crit Rev Toxicol; 2010 Jan; 40(2):101-25. PubMed ID: 20085479
    [Abstract] [Full Text] [Related]

  • 27. What do I tell my patients about drinking water and the risk of bladder cancer?
    Moyad MA.
    Urol Nurs; 2003 Oct; 23(5):371-7. PubMed ID: 14621363
    [Abstract] [Full Text] [Related]

  • 28. Lung cancer and exposure to arsenic in rural Bangladesh.
    Mostafa MG, McDonald JC, Cherry NM.
    Occup Environ Med; 2008 Nov; 65(11):765-8. PubMed ID: 18417558
    [Abstract] [Full Text] [Related]

  • 29. Neurosensory effects of chronic human exposure to arsenic associated with body burden and environmental measures.
    Otto D, Xia Y, Li Y, Wu K, He L, Telech J, Hundell H, Prah J, Mumford J, Wade T.
    Hum Exp Toxicol; 2007 Mar; 26(3):169-77. PubMed ID: 17439919
    [Abstract] [Full Text] [Related]

  • 30. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U, Dieter HH, Klein D, Schneider K.
    Crit Rev Toxicol; 2009 Mar; 39(4):271-98. PubMed ID: 19235533
    [Abstract] [Full Text] [Related]

  • 31. Arsenic and bladder cancer: observations and suggestions.
    Radosavljević V, Jakovljević B.
    J Environ Health; 2008 Oct; 71(3):40-2. PubMed ID: 18990932
    [Abstract] [Full Text] [Related]

  • 32. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
    Gentry PR, Yager JW, Clewell RA, Clewell HJ.
    Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
    [Abstract] [Full Text] [Related]

  • 33. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000.
    Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH.
    Am J Epidemiol; 2007 Dec 15; 166(12):1381-91. PubMed ID: 17875584
    [Abstract] [Full Text] [Related]

  • 34. High exposure to arsenic from drinking water at several localities in eastern Croatia.
    Cavar S, Klapec T, Grubesić RJ, Valek M.
    Sci Total Environ; 2005 Mar 01; 339(1-3):277-82. PubMed ID: 15740776
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of micronucleus induction in a Chilean population environmentally exposed to arsenic.
    Martínez V, Creus A, Venegas W, Arroyo A, Beck JP, Gebel TW, Surrallés J, Marcos R.
    Mutat Res; 2004 Nov 14; 564(1):65-74. PubMed ID: 15474412
    [Abstract] [Full Text] [Related]

  • 36. A human PBPK/PD model to assess arsenic exposure risk through farmed tilapia consumption.
    Ling MP, Liao CM.
    Bull Environ Contam Toxicol; 2009 Jul 14; 83(1):108-14. PubMed ID: 19452117
    [Abstract] [Full Text] [Related]

  • 37. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
    Chen YC, Su HJ, Guo YL, Houseman EA, Christiani DC.
    Cancer Causes Control; 2005 Mar 14; 16(2):75-81. PubMed ID: 15868449
    [Abstract] [Full Text] [Related]

  • 38. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
    Karagas MR, Stukel TA, Tosteson TD.
    Int J Hyg Environ Health; 2002 Mar 14; 205(1-2):85-94. PubMed ID: 12018020
    [Abstract] [Full Text] [Related]

  • 39. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.
    Yoshida T, Yamauchi H, Fan Sun G.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):243-52. PubMed ID: 15276403
    [Abstract] [Full Text] [Related]

  • 40. Nitrate in public water supplies and risk of bladder cancer.
    Ward MH, Cantor KP, Riley D, Merkle S, Lynch CF.
    Epidemiology; 2003 Mar 01; 14(2):183-90. PubMed ID: 12606884
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.